Glycoprotein IIIa Pl(A) polymorphism associates with progression of coronary artery disease and with myocardial infarction in an autopsy series of middle-aged men who died suddenly

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 19, Issue 10, 1999, Pages 2573-2578

  Mikkelsson, Jussi ^a,c   Perola, Markus ^b   Laippala, Pekka ^c   Savolainen, Vesa ^d   Pajarinen, Jarkko ^d   Lalu, Kaisa ^d   Penttilä, Antti ^d   Karhunen, Pekka J ^a,e  

^a TAMPERE UNIVERSITY HOSPITAL   (Finland)

^b NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^c TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^d Department of Forensic Medicine ^*  (Finland)

^e UNIVERSITY OF EASTERN FINLAND   (Finland)

Author keywords

Coronary thrombosis; Genetics; Myocardial infarction; Platelet glycoprotein GPIIb IIIa complex; Polymorphisms

Indexed keywords

FIBRINOGEN RECEPTOR; GLYCOPROTEIN IIIA;

ADULT; AGED; ARTICLE; AUTOPSY; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; DISEASE ASSOCIATION; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN POLYMORPHISM; SUDDEN DEATH;

EID: 0032834768     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.19.10.2573     Document Type: Article

References (44)

1. Chesebro JH, Fuster V. Thrombosis in unstable angina. N Engl J Med. 1992;327:192-194.
2. Badimon L, Chesebro JH, Badimon JJ. Thrombus formation on ruptured atherosclerotic plaques and rethrombosis on evolving thrombi. Circulation 1992;86(suppl III):III-74-III-85.
3. Lefkovits J, Plow EF, Topol EJ. Platelet glycoprotein IIb/IIIa receptors in cardiovascular medicine. N Engl J Med. 1994;332:1553-1558.
4. Fuster V, Badimon JJ, Badimon L, Chesebro JH. The pathogenesis of coronary artery disease and the acute coronary syndromes. N Engl J Med. 1992;326:242-250.
5. Mehta D, Curwin J, Gomes A, Fuster V. Sudden death in coronary artery disease: acute ischemia versus myocardial substrate. Circulation. 1997; 96:3215-3223.
6. Davies MG, Hagen PO. Pathobiology of intimal hyperplasia. Br J Surg. 1994;81:1254-1269.
7. Ruoslahti E, Engvall E. Integrins and vascular extracellular matrix assembly. J Clin Invest. 1997;100:53S-56S.
8. Pittilo RM. Cigarette smoking and endothelial injury: a review. Adv Exp Med Biol. 1990;273:61-78.
9. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature. 1993;362:801-809.
10. Shattil SJ. Function and regulation of the β3 integrins in hemostasis and vascular biology. Thromb Haemost. 1995;74:149-155.
11. Taddei S, Salvetti A. Endothelial dysfunction in hypertension. Adv Exp Med Biol. 1997;423:235-246.
12. Gimbrone MAJ, Cybulsky MI, Kume N, Collins T, Resnick N. Vascular endothelium: an integrator of pathophysiological stimuli in atherogenesis. Ann N Y Acad Sci. 1995;748:122-132.
13. Ross R. Mechanisms of disease: atherosclerosis: an inflammatory disease. N Engl J Med. 1999;340:115-126.
14. Schini-Kerth VB, Bassus S, Fisslthaler B, Kirchmaier CM, Busse R. Aggregating human platelets stimulate the expression of thrombin receptors in cultured vascular smooth muscle cells via the release of transforming growth factor-β1 and platelet-derived growth factor AB. Circulation. 1997;96:3888-3896.
15. Stouffer GA, Hu Z, Sajid M, Li H, Jin G, Nakada MT, Hanson SR, Runge MS. β3 Integrins are upregulated after vascular injury and modulate thrombospondin-and thrombin-induced proliferation of cultured smooth muscle cells. Circulation. 1998;97:907-915.
16. Honda S, Honda Y, Bauer B, Ruan C, Kunicki TJ. The impact of three-dimensional structure on the expression of PlA alloantigens on human integrin β3. Blood. 1995;86:234-242.
17. Weiss EJ, Bray PF, Tayback M, Schulman SP, Kickler TS, Becker LC, Weiss JL, Gerstenblith G, Goldschmidt-Clermont PJ. A polymorphism of a platelet glycoprotein receptor as an inherited risk factor for coronary thrombosis. N Engl J Med. 1996;334:1090-1094.
18. A polymorphism and myocardial infarction. N Engl J Med. 1996;335: 1071-1072.
19. A polymorphism and myocardial infarction. N Engl J Med. 1996;335: 1073-1074.
20. A polymorphism in young men with myocardial infarction. Lancet. 1996; 348:485-486.
21. Osborn SV, Hampton KK, Smillie D, Channer KS, Daly ME. Platelet glycoprotein IIIa gene polymorphism and myocardial infarction. Lancet. 1996;348:1309-1310.
22. A polymorphism and myocardial infarction. N Engl J Med. 1996;335: 1072-1073.
23. A1/A2 polymorphism of platelet glycoprotein IIIa and risks of myocardial infarction, stroke, and venous thrombosis. Lancet. 1997;349:385-388.
24. A polymorphism of glycoprotein IIb/IIIa and the fibrinogen Bβ 448 polymorphism with myocardial infarction and extent of coronary artery disease. Circulation. 1997;96:1424-1431.
25. Walter DH, Schächinger V, Elsner M, Dimmeler S, Zeiher AM. Platelet glycoprotein IIIa polymorphisms and risk of coronary stent thrombosis. Lancet. 1997;350:1217-1219.
26. A2(+) individuals. Blood. 1996;88:26a. Abstract.
27. A2). Circulation. 1997; 96(suppl I):I-660. Abstract.
28. Lasne D, Krenn M, Pingault V, Arnaud E, Fiessinger JN, Aiach M, Rendu F. Interdonor variability of platelet response to thrombin receptor activation: influence of PlA2 polymorphism. Br J Haematol. 1997;99: 801-807.
29. Pekkanen J, Nissinen A, Puska P, Punsar S, Karvonen MJ. Risk factors and 25 year risk of coronary heart disease in a male population with a high incidence of the disease: the Finnish cohorts of the Seven Countries Study. BMJ. 1989;299:81-85.
30. De la Chapelle A. Disease gene mapping in isolated human populations: the example of Finland. Am J Hum Genet. 1993;30:857-865.
31. Karhunen PJ, Männikkö A, Penttilä A, Liesto K. Diagnostic angiography in postoperative autopsies. Am J Forensic Med Pathol. 1989;303-309.
32. Stary HC, Chandler AB, Dinsmore RE, Fuster V, Glagov S Insull W Jr, Rosenfeld ME, Schwartz CJ, Wagner WD, Wissler RW. A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis: a report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Circulation. 1995;92:1355-1374.
33. Kekomaki S, Partanen J, Kekomaki R. Platelet alloantigens HPA-1, -2, -3, -5 and -6 in Finns. Transfus Med. 1995;5:193-198.
34. Mann JM, Davies MJ. Assessment of the severity of coronary artery disease at postmortem examination: are the measurements clinically valid? Br Heart J. 1995;74:528-530.
35. Cooke GE, Bray PF, Hamlington JD, Pham DM, Goldschmidt-Clermont PJ. PlA2 polymorphism and efficacy of aspirin. Lancet. 1998;351:1253.
36. Faraday N, Goldschmidt-Clermont PJ, Bray PF. Gender differences in platelet GPIIb-IIIa activation. Thromb Haemost. 1997;77:748-754.
37. Farb A, Burke AP, Tang AL, Liang TY, Mannan P, Smialek J, Virmani R. Coronary plaque erosion without rupture into a lipid core: a frequent cause of coronary thrombosis in sudden coronary death. Circulation. 1996;93:1354-1363.
38. Davies MJ, Thomas A. Thrombosis and acute coronary-artery lesions in sudden cardiac ischemic death. N Engl J Med. 1984;310:1137-1140.
39. Davies MJ, Bland JM, Hangartner JR, Angelini A, Thomas AC. Factors influencing the presence or absence of acute coronary artery thrombi in sudden ischemic death. Eur Heart J. 1989;10:203-208.
40. Farb A, Tang AL, Burke AP, Sessums L, Liang Y, Virmani R. Sudden coronary death: frequency of active coronary lesions, inactive coronary lesions, and myocardial infarction. Circulation. 1995;92: 1701-1709.
41. Warnes CA, Roberts WC. Sudden coronary death: comparison of patients with to those without coronary thrombus at necropsy. Am J Cardiol. 1984;54:1206-1211.
42. Leach IH, Blundell JW, Rowley JM, Turner DR. Acute ischaemic lesions in death due to ischaemic heart disease: an autopsy study of 333 cases of out-of-hospital death. Eur Heart J. 1995;16:1181-1185.
43. Pastinen T, Perola M, Niini P, Terwilliger J, Salomaa V, Vartiainen E, Peltonen L, Syvanen A. Array-based multiplex analysis of candidate genes reveals two independent and additive genetic risk factors for myocardial infarction in the Finnish population. Hum Mol Genet. 1998;7: 1453-1462.
44. A polymorphism in the progression of abdominal aortic atherosclerosis. Atherosclerosis. 1999. In press.